- United Kingdom
- /
- Beverage
- /
- AIM:FEVR
There Are Reasons To Feel Uneasy About Fevertree Drinks' (LON:FEVR) Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. However, after investigating Fevertree Drinks (LON:FEVR), we don't think it's current trends fit the mold of a multi-bagger.
Understanding Return On Capital Employed (ROCE)
For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. The formula for this calculation on Fevertree Drinks is:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.061 = UK£16m ÷ (UK£314m - UK£61m) (Based on the trailing twelve months to December 2023).
Therefore, Fevertree Drinks has an ROCE of 6.1%. In absolute terms, that's a low return and it also under-performs the Beverage industry average of 15%.
Check out our latest analysis for Fevertree Drinks
Above you can see how the current ROCE for Fevertree Drinks compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Fevertree Drinks .
What The Trend Of ROCE Can Tell Us
On the surface, the trend of ROCE at Fevertree Drinks doesn't inspire confidence. Over the last five years, returns on capital have decreased to 6.1% from 41% five years ago. However it looks like Fevertree Drinks might be reinvesting for long term growth because while capital employed has increased, the company's sales haven't changed much in the last 12 months. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line.
The Key Takeaway
In summary, Fevertree Drinks is reinvesting funds back into the business for growth but unfortunately it looks like sales haven't increased much just yet. And investors appear hesitant that the trends will pick up because the stock has fallen 51% in the last five years. All in all, the inherent trends aren't typical of multi-baggers, so if that's what you're after, we think you might have more luck elsewhere.
On a final note, we've found 2 warning signs for Fevertree Drinks that we think you should be aware of.
While Fevertree Drinks isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About AIM:FEVR
Fevertree Drinks
Engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally.
Flawless balance sheet with reasonable growth potential and pays a dividend.